A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19

Autor: Oriol, Mitjà, Marc, Corbacho-Monné, Maria, Ubals, Andrea, Alemany, Clara, Suñer, Cristian, Tebé, Aurelio, Tobias, Judith, Peñafiel, Ester, Ballana, Carla A, Pérez, Pol, Admella, Núria, Riera-Martí, Pep, Laporte, Jordi, Mitjà, Mireia, Clua, Laia, Bertran, Maria, Sarquella, Sergi, Gavilán, Jordi, Ara, Josep M, Argimon, Gabriel, Cuatrecasas, Paz, Cañadas, Aleix, Elizalde-Torrent, Robert, Fabregat, Magí, Farré, Anna, Forcada, Gemma, Flores-Mateo, Cristina, López, Esteve, Muntada, Núria, Nadal, Silvia, Narejos, Aroa, Nieto, Nuria, Prat, Jordi, Puig, Carles, Quiñones, Ferran, Ramírez-Viaplana, Juliana, Reyes-Urueña, Eva, Riveira-Muñoz, Lidia, Ruiz, Sergi, Sanz, Alexis, Sentís, Alba, Sierra, César, Velasco, Rosa M, Vivanco-Hidalgo, Juani, Zamora, Jordi, Casabona, Martí, Vall-Mayans, Camila, González-Beiras, Bonaventura, Clotet, Esther, Diaz Soler

Publikováno v: The New England Journal of Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
New England Journal of Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

BackgroundCurrent strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. Hydroxychloroquine has been proposed as a postexposure therapy to prevent coronavirus di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::791e4bc67140e052060e45a06d9cfd09
http://hdl.handle.net/2445/180762

Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial

Autor: Lidia Ruiz, Núria Nadal, Jordi Ara, Laia Bertran, Paz Cañadas, Maria Sarquella, Carles Quiñones, Jordi Puig, Pol Admella, Anna Forcada, Aroa N Gil-Ortega, Gemma Flores-Mateo, Pep Laporte, César Velasco, Ferran Ramírez-Viaplana, Bonaventura Clotet, Marc Corbacho-Monné, Eva Riveira-Muñoz, Clara Suñer, Aurelio Tobias, Aleix Elizalde-Torrent, Josep M. Argimon, Jordi Casabona, Alba Sierra, Núria Riera-Martí, Alexis Sentís, Magí Farré, Camila G-Beiras, Ester Ballana, Cristian Tebé, Nuria Prat, Gabriel Cuatrecasas, Judith Peñafiel, Oriol Mitjà, Juliana Reyes-Ureña, Jordi Mitjà, Mireia Clua, Maria Ubals, Carla A. Pérez, Andrea Alemany, Sergi Gavilán, Martí Vall-Mayans, Robert Fabregat, Rosa Maria Vivanco-Hidalgo, Silvia Narejos, Esteve Muntada

Publikováno v: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Digital.CSIC. Repositorio Institucional del CSIC

No effective treatments for coronavirus disease 2019 (COVID-19) exist. We aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be efficacious for outpatients with COVID-19.
The authors thank Gerard Carot-Sans, PhD, for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf71bea63770135517016b40e61636c
https://pubmed.ncbi.nlm.nih.gov/32674126